Analyst Price Targets — ASPI
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| December 4, 2025 11:19 am | Derek Soderberg | Cantor Fitzgerald | $13.00 | $5.73 | TheFly | ASP Isotopes initiated with an Overweight at Cantor Fitzgerald |
| October 27, 2025 11:06 am | Alex Fuhrman | Loop Capital Markets | $15.00 | $9.95 | StreetInsider | Lucid Capital Markets Starts ASP Isotopes Inc. (ASPI) at Buy |
| October 4, 2024 5:44 am | George Gianarikas | Canaccord Genuity | $4.50 | $3.01 | TheFly | ASP Isotopes initiated with a Buy at Canaccord |
| April 17, 2024 6:46 am | Heiko Ihle | H.C. Wainwright | $5.50 | $3.16 | StreetInsider | ASP Isotopes Inc. (ASPI) PT Raised to $5.50 at H.C. Wainwright |
Latest News for ASPI
First Commercial Shipments Expected Across Multiple Isotopes in 2026 Expect to Obtain Helium Phase 1 Nameplate Capacity in Q3 2026 EBITDA Target of Greater Than $300 Million in 2031 Cash, Cash Equivalents and Short-Term Marketable Securities of $333 million as of December 31, 2025 Business Update Conference Call Scheduled for 8:00 AM ET on April 13, 2026 DALLAS, April 13, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc.…
DALLAS, April 10, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today announced that Paul Mann, Executive Chairman and Chief Executive Officer at ASP Isotopes, will host a business update conference call and webcast on…
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Philadelphia, Pennsylvania--(Newsfile Corp. - March 26, 2026) - What is Happening? Grabar Law Office is investigating claims on behalf of shareholders of ASP Isotopes Inc. ("ASP Isotopes" or the "Company") (NASDAQ: ASPI).
Collaboration to develop a cutting-edge lithium laser enrichment research facility in the UK Collaboration to develop a cutting-edge lithium laser enrichment research facility in the UK
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ASPI.
U.S. House Trading
No House trades found for ASPI.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.